HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Humpert, P. M. Articles by Bierhaus, A. Search for Related Content PubMed PubMed Citation Articles by Humpert, P. M. Articles by Bierhaus, A. Social Bookmarking                What's this?

SDF-1 Genotype Influences Insulin-Dependent Mobilization of Adult Progenitor Cells in Type 2 Diabetes

From the Department of Medicine I, University Clinics Heidelberg, Heidelberg, Germany

Address correspondence and reprint requests to Dr. Angelika Bierhaus, PHD, Medizinische Klinik 1, University of Heidelberg, INF 410, 69120 Heidelberg, Germany. E-mail: angelika.bierhaus@med.uni-heidelberg.de

Abbreviations: pBMC, peripheral mononuclear cell • PC, progenitor cell

The first 20% of the full text of this article appears below.

	INTRODUCTION

 
CD34⁺/CD133⁺ circulating adult progenitor cells (PCs) play an important role in tissue repair in metabolic disease. PCs have a certain plasticity to differentiate into cells with tissue-specific phenotypes (1–3). In diabetic mice, therapeutic use of PCs in models of hindlimb ischemia and wound healing was particularly effective, suggesting a diabetes-dependent defect in PC function (4,5). Accordingly, in vitro outgrowth and angiogenic function of endothelial PCs differentiating from PCs (1) is diminished in patients with cardiovascular risk factors and in type 1 and type 2 diabetes (6–8). From clinical studies it is evident that insulin therapy is a factor determining cardiovascular complications and mortality in diabetes (9,10). It can therefore be speculated that insulin might influence mobilization of PCs in type 2 diabetes. In view of the strong genetic background for the development of late diabetes complications, we asked whether the SDF1-3'A/G genotype known to enhance PC mobilization (11) might be of influence.

	RESEARCH DESIGN AND METHODS

 
In the pilot study presented here, we quantified the number of PCs by flourescence-activated cell sorter (FACS) analysis in 23 patients with poorly controlled type 2 diabetes (HbA_1c 10.6 ± 1.6%, fasting glucose 15.9 ± 4.5 mmol/l) and 10 age-matched control subjects (59 ± 14 vs. 58 ± 10 years) without history of diabetes (HbA_1c 5.4 ± 0.5%). After 5.4 ± 1.6 weeks of treatment with (additional) insulin, 11 patients from this cohort had a follow-up . . . [Full Text of this Article]

FACS analysis and genotyping
Statistical analysis

	RESULTS

 

	CONCLUSIONS

 

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. P. Fadini, I. Baesso, C. Agostini, E. Cuccato, G. B. Nardelli, A. Lapolla, and A. Avogaro Maternal Insulin Therapy Increases Fetal Endothelial Progenitor Cells During Diabetic Pregnancy Diabetes Care, April 1, 2008; 31(4): 808 - 810. [Full Text] [PDF]

				G. P. Fadini, S. Sartore, C. Agostini, and A. Avogaro Significance of Endothelial Progenitor Cells in Subjects With Diabetes Diabetes Care, May 1, 2007; 30(5): 1305 - 1313. [Full Text] [PDF]

				G. C. Schatteman, M. Dunnwald, and C. Jiao Biology of bone marrow-derived endothelial cell precursors Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H1 - H18. [Abstract] [Full Text] [PDF]

				P. M. Humpert, M. J. Battista, A. Lammert, P. Reismann, Z. Djuric, G. Rudofsky Jr, M. Zorn, M. Morcos, H.-P. Hammes, P. P. Nawroth, et al. Association of stromal cell-derived factor 1 genotype with diabetic foot syndrome and macrovascular disease in patients with type 2 diabetes. Clin. Chem., June 1, 2006; 52(6): 1206 - 1208. [Full Text] [PDF]